Subscribe To
Johnson & johnson relinquishes top spot to eli lilly, shares undervalued amid technical risks
Eli Lilly has surpassed Johnson & Johnson in market cap for the first time, driven by LLY's breakthroughs in o...
June 8, 2023, 1:23 pm
Terns pharmaceuticals to present at goldman sachs 44th annual global healthcare conference
FOSTER CITY, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
June 6, 2023, 4:30 pm
Novo nordisk: dominating in diabetes and obesity
Novo Nordisk has performed extremely well in the past few years as it continues to dominate in diabetes and ob...
June 5, 2023, 1:13 am
Terns pharmaceuticals: upcoming obesity data is one of many catalysts coming up
Terns Pharmaceuticals has a promising pipeline with potential best-in-class therapies for obesity and N...
June 1, 2023, 6:47 pm
Novo nordisk (nvo) should remain supported & resume rally
Novo Nordisk A/S (NVO), a healthcare company engages in the research, development, manufacture and marketing of the pharmaceutical products worldwide....
May 30, 2023, 9:19 pm
Pfizer: the new oral weight loss therapy could be a game changer
Pfizer has declined over 36% in the past two years, as investors worry about the company's growth post-COVID. The company's new oral weight loss thera...
May 30, 2023, 12:11 am
Overweight in heterozygous fh tied to even higher cad risk
The relatively high rates of overweight and obesity among patients with familial hypercholesterolemia s...
May 26, 2023, 9:59 pm
Structure therapeutics initiates phase 2a study of oral glp-1 agonist gsbr-1290 for the treatment of type 2 diabetes and obesity
12-week Phase 2a and Phase 1b multiple ascending dose (MAD) topline results expected to be announced in latter half of fourth quarter 2023 Ethnobridgi...
May 25, 2023, 8:30 pm
Novo nordisk (nvo) announces positive obesity program data
Novo Nordisk's (NVO) late-stage study of once-daily oral semaglutide 25 mg and 50 mg in obesity shows s...
May 23, 2023, 2:39 pm
Novo nordisk: flourishing financials and emerging opportunities in diabetes and obesity
Novo Nordisk showed substantial Q1 2023 growth, with a 27% rise in net sales and a 39% boost in net profit. Diabetes and ...
May 23, 2023, 11:40 am
obesity drug brings heart health benefit alongside weight loss- study
Taking Novo Nordisk's new obesity drug may help reduce the risk of heart disease as well as boosting we...
May 19, 2023, 6:06 pm
Vivus’ qsiva in combination with a digital lifestyle intervention leads to significant weight loss and decreased cardiovascular risk in patients with obesity
— Poster presented at the 30th European Congress on obesity (ECO 2023) shows addition of QSIVA provid...
May 17, 2023, 7:30 am
Is novo nordisk stock a screaming buy right now?
Novo Nordisk's rocket-fueled growth in type 2 diabetes and obesity treatment has made its stock a winni...
May 16, 2023, 10:45 am
Biorestorative therapies receives notice of allowance by the japanese patent and trademark office for a patent application related to its thermostem® program
—Upon issuance, patent will be the fourth Japanese patent to issue for the ThermoStem® program targeting ob...
May 15, 2023, 11:00 am
In one chart: eli lilly on track to close with a higher market cap than j&j for first time since 1997
Eli Lilly’s stock has benefited from positive data in trials of an obesity drug and a treatment for A...
May 12, 2023, 4:55 pm
Novo nordisk, a top 1% stock, dives as sales of obesity blockbuster drug miss
Novo Nordisk stock slumped Thursday after its weight loss blockbuster, Wegovy, missed sales expectations despite rocketing demand. The post Novo Nordi...
May 4, 2023, 10:44 am
Novo nordisk stock skids as obesity drug wegovy misses expectations
Novo Nordisk stock skidded Thursday after the company beat overall sales and profit expectations, but obesity<...
May 4, 2023, 9:16 am
Novo nordisk cuts some supply of wegovy obesity drug as demand grows
Karsten Munk Knudsen, chief financial officer at Novo Nordisk, says the company is halving the supply of starter doses of its Wegovy weight loss drug ...
May 4, 2023, 7:15 am
Novo nordisk cuts some u.s. supply of wegovy obesity drug as demand soars
Novo Nordisk said Thursday that it was cutting the supply of some doses of its popular obesity drug in...
May 4, 2023, 6:55 am
obesity drug could be a 'big upside' for eli lilly, says wells fargo's mohit bansal
Mohit Bansal, Wells Fargo managing director, joins 'Fast Money' to talk Eli Lilly drug trials, it's competition with Biogen for an alzheimer's drug, a...
May 3, 2023, 7:19 pm